Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2018

Primary Completion Date

May 10, 2019

Study Completion Date

August 22, 2020

Conditions
Total Hip Arthroplasty
Interventions
DRUG

Quadratus Lumborum Block (QLB)

Under ultrasound guidance, the needle will be advanced to the posterior border of the quadratus lumborum muscle. After negative aspiration, a bolus of 40 mL of 0.25% bupivacaine with 1:400,000 epinephrine will be injected in 5 mL aliquots, ensuring proper placement of needle tip and appropriate spread of local anesthetic.

DRUG

Standard of Care

This is currently the standard of care, no local anesthetic will be injected. Pain will be managed with parenteral and oral medication.

Trial Locations (1)

35233

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER

NCT03408483 - Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter